Cargando…

Axitinib: Newly Approved for Renal Cell Carcinoma

Detalles Bibliográficos
Autor principal: Tyler, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093354/
https://www.ncbi.nlm.nih.gov/pubmed/25031963
_version_ 1782325710321352704
author Tyler, Timothy
author_facet Tyler, Timothy
author_sort Tyler, Timothy
collection PubMed
description
format Online
Article
Text
id pubmed-4093354
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-40933542014-07-16 Axitinib: Newly Approved for Renal Cell Carcinoma Tyler, Timothy J Adv Pract Oncol Review Article Harborside Press 2012 2012-09-01 /pmc/articles/PMC4093354/ /pubmed/25031963 Text en Copyright © 2012, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Tyler, Timothy
Axitinib: Newly Approved for Renal Cell Carcinoma
title Axitinib: Newly Approved for Renal Cell Carcinoma
title_full Axitinib: Newly Approved for Renal Cell Carcinoma
title_fullStr Axitinib: Newly Approved for Renal Cell Carcinoma
title_full_unstemmed Axitinib: Newly Approved for Renal Cell Carcinoma
title_short Axitinib: Newly Approved for Renal Cell Carcinoma
title_sort axitinib: newly approved for renal cell carcinoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093354/
https://www.ncbi.nlm.nih.gov/pubmed/25031963
work_keys_str_mv AT tylertimothy axitinibnewlyapprovedforrenalcellcarcinoma